Pancreatic Cancer

Pancreatic cancer at a glance

Pancreatic ductal adenocarcinoma (PDAC) is the predominant histologic type of pancreatic cancer (PC) and is the 10th most common cancer diagnosis among men and the 9th most common among women in the US [7]. However, is the fourth leading cause of cancer-related death in occidental countries and has the worst prognosis of all major malignancies with just a 6% five-year survival rate [8] and a median survival of less than 6 months [7]. Incidence of PC in the US and most of developed countries continue to rise with forecast claiming that it will be the second most fatal cancer in the US by 2030. [9]



  • 7. Cancer Facts & Figures. Pancreatic cancer 2013
  • 8. Lin et al. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer. Mol. BioSyst. 2016, 12, 2883-2892.
  • 9. Rahib et al. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Res; 2014; 74(11); 2913–2.

Comments are closed, but trackbacks and pingbacks are open.